Finance

Lists
RMD:ASX
Resmed CDI
34,44 A$
-0,49%
(-0,17) 1D
6 қар., 10:09:02 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
34,48 A$
High
34,64 A$
Low
34,39 A$
Mkt. cap
33,66 млрд
Avg. vol.
1,63 млн
Volume
627,32 м.
52-wk high
39,94 A$
52-wk low
25,50 A$
Shares outstanding
140,66 млн
No. of employees
11 мың
Open
34,48 A$
High
34,64 A$
Low
34,39 A$
Mkt. cap
33,66 млрд
Avg. vol.
1,63 млн
Volume
627,32 м.
52-wk high
39,94 A$
52-wk low
25,50 A$
Shares outstanding
140,66 млн
No. of employees
11 мың
News stories
From web sources and news partners
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11,4 мың
Foundedмау. 1989
HeadquartersСан-Диего, Калифорния, Америка Құрама Штаттары
SectorHealth Care
IndustryMedical device
Websiteresmed.com
Last report
2026 ж. 29 қаз.
Fiscal period
Q1 2027
0,29 $ / 0,27 $
+8,81%beat
Revenue / Est. (USD)
1,41 млрд / 1,39 млрд
+1,55%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
1,42 млрд
1,43 млрд
1,46 млрд
1,41 млрд
Cost of goods sold
536,28 млн
532,58 млн
594,13 млн
536,45 млн
Cost of revenue
536,28 млн
532,58 млн
594,13 млн
536,45 млн
Research and development expenses
90,97 млн
94,27 млн
105,72 млн
101,53 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
275,70 млн
279,80 млн
293,36 млн
284,20 млн
Operating expense
386,24 млн
393,16 млн
417,88 млн
385,73 млн
Total operating expenses
922,51 млн
925,74 млн
1,01 млрд
922,18 млн
Operating income
500,30 млн
505,67 млн
451,64 млн
492,64 млн
Other non operating income
42,00 мың
181,00 м.
4,40 млн
2,95 млн
EBT including unusual items
496,15 млн
502,31 млн
474,16 млн
539,16 млн
EBT excluding unusual items
504,48 млн
518,30 млн
476,09 млн
511,31 млн
Income tax expense
103,56 млн
103,58 млн
90,73 млн
120,74 млн
Effective tax rate
20,87%
20,62%
19,14%
22,39%
Other operating expenses
-
-
-
-
Net income
392,59 млн
398,73 млн
383,43 млн
418,41 млн
Net profit margin
27,59%
27,86%
26,20%
29,57%
Earnings per share
2,81
0,29
0,30
0,29
Interest and investment income
4,46 млн
3,80 млн
31,76 млн
21,20 млн
Interest expense
-
-
-
-4,81 млн
Net interest expenses
4,46 млн
3,80 млн
31,76 млн
16,38 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
543,79 млн
558,22 млн
490,13 млн
534,38 млн
Gain or loss from assets sale
-
-
-
-61,78 млн
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары